This announcement is a separate document:
信立泰：华英证券有限责任公司关于深圳信立泰药业股份有限公司部分董事、高级管理人员拟参与控股子公司股权激励计划暨关联交易的核查意见
Xinlitai: Huaying Securities Co., Ltd.'s inspection opinions on the proposed participation of some directors and senior managers of Shenzhen Xinlitai Pharmaceutical Co., Ltd. in the holding subsidiary's equity incentive plan and related transactions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.